Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Depreciation and Depletion (2024 - 2025)

Historic Depreciation and Depletion for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $300000.0.

  • Xilio Therapeutics' Depreciation and Depletion fell 2500.0% to $300000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is 1111.11% down from last year.
  • Per Xilio Therapeutics' latest filing, its Depreciation and Depletion stood at $300000.0 for Q3 2025, which was down 2500.0% from $400000.0 recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Depreciation and Depletion registered a high of $500000.0 during Q1 2025, and its lowest value of $300000.0 during Q3 2025.